As CDMO giants Wuxi AppTec and WuXi Biologics come under mounting scrutiny for their alleged ties to Chinese government officials, they are losing a key ally in Wash...

Up to 2,000 Evonik workers worldwide will be laid off as the German chemicals company and contract drug manufacturer looks to cut costs. Over the last few months,...

GSK's antiretroviral HIV medicine Tivicay (dolutegravir) has been recommended by the World Health Organization (WHO) since 2018 as a preferred treatment for the viru...

In its continuing expansion blitz, Almac has completed new two facilities at its headquarters in Craigavon, Northern Ireland, which will expand the capacity of the C...

AstraZeneca CEO Pascal Soriot, who has been critical of the U.K.’s business environment for the life sciences industry, is directing a big chunk of money into the Bi...

The world’s leading testing, inspection and certification company announced today that its Fairfield laboratory has earned its ISO/IEC 17025:2017 certification. ...

With a new CEO tapped to drive EuroAPI’s turnaround, the Sanofi spinoff is proposing drastic steps to get its business on track, including potential layoffs and site...

The first 12 months on the market for Apellis’ geographic atrophy (GA) drug Syfovre have been a roller-coaster ride. And there’s still more loops to negotiate. On...

As part of a long-term partnership between Spain’s Laboratorios Farmacéuticos Rovi and Moderna, the former company is bringing a new plant into the mix for...

After a busy 2023 marked by multiple drug approvals, UCB isn’t resting on its laurels. This year, the company is focused on growing its blockbuster hopeful Bimzel...